Published in Hepatitis Weekly, December 16th, 1996
Researcher Thierry Bizollon and colleagues found the combination treatment to be well-tolerated in their group of transplant patients ("New Approaches to Treatment of Recurrent HCV Following Liver Transplantation Using Ribavirin," Transplantation Proceedings, October 1996;XXVIII(5):2842-2843).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.